Sandrock Alfred
Insider CIK 1577061 · VYGR President and CEO, Director · BIIB Head of Research & Development · NBIX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VYGR Voyager Therapeutics, Inc. | S Sale | 2026-04-02 | 2026-04-03 | 11,511 | $3.87 | $44.5K | 472,549 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2026-02-24 | 2026-02-26 | 14,197 | $3.79 | $53.8K | 484,060 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2026-02-18 | 2026-02-20 | 11,732 | $3.41 | $40.0K | 498,257 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2026-02-10 | 2026-02-11 | 12,192 | $3.78 | $46.1K | 509,989 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2026-02-06 | 2026-02-10 | 402,500 | — | $0 | 402,500 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award | 2026-02-06 | 2026-02-10 | 86,250 | — | $0 | 522,181 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2025-04-02 | 2025-04-04 | 10,885 | $3.43 | $37.3K | 430,931 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2025-02-21 | 2025-02-24 | 290,000 | — | $0 | 290,000 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award | 2025-02-21 | 2025-02-24 | 145,000 | — | $0 | 441,816 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2025-02-20 | 2025-02-24 | 11,702 | $4.24 | $49.6K | 296,816 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2025-02-11 | 2025-02-12 | 16,644 | $4.45 | $74.1K | 308,518 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2024-04-02 | 2024-04-03 | 12,115 | $9.86 | $119.5K | 322,839 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2024-02-21 | 2024-02-22 | 13,033 | $7.46 | $97.2K | 334,954 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2024-02-09 | 2024-02-16 | 260,000 | — | $0 | 260,000 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award | 2024-02-09 | 2024-02-16 | 130,000 | — | $0 | 347,987 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2023-04-03 | 2023-04-05 | 7,437 | $7.83 | $58.2K | 214,618 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2023-02-17 | 2023-02-22 | 240,000 | — | $0 | 240,000 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award | 2023-02-17 | 2023-02-22 | 120,000 | — | $0 | 222,055 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2022-03-22 | 2022-03-23 | 940,600 | — | $0 | 940,600 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award | 2022-03-22 | 2022-03-23 | 100,000 | — | $0 | 100,000 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2022-02-07 | 2022-02-09 | 44,000 | — | $0 | 44,000 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2021-06-07 | 2021-06-09 | 7,672 | $440.00 | $3.38M | 10,169 | SEC↗ |
| BIIB BIOGEN INC. | A Award deriv | 2021-02-18 | 2021-02-22 | 14,500 | — | $0 | 14,500 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2021-02-12 | 2021-02-17 | 1,446 | — | $0 | 5,442 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2021-02-12 | 2021-02-17 | 1,996 | — | $0 | 3,446 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2021-02-12 | 2021-02-17 | 1,708 | — | $0 | 10,352 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2021-02-12 | 2021-02-17 | 1,300 | — | $0 | 1,466 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2021-02-12 | 2021-02-17 | 1,466 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2021-02-12 | 2021-02-17 | 2,310 | — | $0 | 8,042 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2021-02-12 | 2021-02-17 | 577 | $278.03 | $160.4K | 19,138 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2021-02-12 | 2021-02-17 | 642 | $278.03 | $178.5K | 18,496 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2021-02-12 | 2021-02-17 | 758 | $278.03 | $210.7K | 17,738 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2021-02-12 | 2021-02-17 | 1,708 | — | $0 | 19,715 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2021-02-12 | 2021-02-17 | 1,533 | $278.03 | $426.2K | 15,261 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2021-02-12 | 2021-02-17 | 1,300 | — | $0 | 16,561 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2021-02-12 | 2021-02-17 | 1,446 | — | $0 | 18,007 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2021-01-27 | 2021-01-29 | 3,728 | — | $0 | 16,794 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2020-11-04 | 2020-11-06 | 1,500 | $350.00 | $525.0K | 13,066 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2020-02-15 | 2020-02-19 | 1,213 | — | $0 | 915 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2020-02-15 | 2020-02-19 | 915 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2020-02-15 | 2020-02-19 | 1,213 | — | $0 | 15,019 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2020-02-15 | 2020-02-19 | 538 | $333.00 | $179.2K | 14,481 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2020-02-12 | 2020-02-14 | 1,422 | — | $0 | 4,106 | SEC↗ |
| BIIB BIOGEN INC. | A Award deriv | 2020-02-12 | 2020-02-14 | 12,060 | — | $0 | 12,060 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2020-02-12 | 2020-02-14 | 2,211 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2020-02-12 | 2020-02-14 | 1,340 | — | $0 | 2,766 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2020-02-12 | 2020-02-14 | 1,583 | — | $0 | 8,747 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2020-02-12 | 2020-02-14 | 1,859 | — | $0 | 6,888 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2020-02-12 | 2020-02-14 | 2,211 | — | $0 | 12,702 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2020-02-12 | 2020-02-14 | 660 | $331.76 | $219.0K | 12,042 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2020-02-12 | 2020-02-14 | 538 | $331.76 | $178.5K | 12,926 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2020-02-12 | 2020-02-14 | 1,583 | — | $0 | 14,509 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2020-02-12 | 2020-02-14 | 703 | $331.76 | $233.2K | 13,806 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2020-02-12 | 2020-02-14 | 1,422 | — | $0 | 13,464 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2019-05-22 | 2019-05-23 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2019-02-22 | 2019-02-26 | 819 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2019-02-22 | 2019-02-26 | 1,663 | — | $0 | 819 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2019-02-22 | 2019-02-26 | 739 | $325.33 | $240.4K | 10,409 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2019-02-22 | 2019-02-26 | 1,663 | — | $0 | 11,148 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2019-02-15 | 2019-02-20 | 808 | — | $0 | 2,128 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2019-02-15 | 2019-02-20 | 1,318 | — | $0 | 2,936 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2019-02-15 | 2019-02-20 | 1,318 | — | $0 | 10,071 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2019-02-15 | 2019-02-20 | 586 | $332.87 | $195.1K | 9,485 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2019-02-12 | 2019-02-14 | 1,104 | — | $0 | 2,211 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2019-02-12 | 2019-02-14 | 1,188 | — | $0 | 5,528 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2019-02-12 | 2019-02-14 | 1,965 | — | $0 | 1,453 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2019-02-12 | 2019-02-14 | 1,453 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2019-02-12 | 2019-02-14 | 1,574 | — | $0 | 6,716 | SEC↗ |
| BIIB BIOGEN INC. | A Award deriv | 2019-02-12 | 2019-02-14 | 10,330 | — | $0 | 10,330 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2019-02-12 | 2019-02-14 | 873 | $319.43 | $278.9K | 7,878 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2019-02-12 | 2019-02-14 | 1,965 | — | $0 | 8,751 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2019-02-12 | 2019-02-14 | 699 | $319.43 | $223.3K | 8,753 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2019-02-12 | 2019-02-14 | 358 | $319.43 | $114.4K | 7,374 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2019-02-12 | 2019-02-14 | 1,104 | — | $0 | 7,732 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2019-02-12 | 2019-02-14 | 1,574 | — | $0 | 9,452 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2019-02-12 | 2019-02-14 | 588 | $319.43 | $187.8K | 6,786 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2018-05-24 | 2018-05-25 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2018-02-27 | 2018-02-28 | 259 | $290.83 | $75.3K | 6,553 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2018-02-23 | 2018-02-27 | 467 | — | $0 | 595 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2018-02-23 | 2018-02-27 | 595 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2018-02-23 | 2018-02-27 | 208 | $292.78 | $60.9K | 6,812 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2018-02-23 | 2018-02-27 | 467 | — | $0 | 7,020 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2018-02-23 | 2018-02-27 | 908 | $293.44 | $266.4K | 6,553 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2018-02-22 | 2018-02-26 | 843 | — | $0 | 2,482 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2018-02-22 | 2018-02-26 | 1,635 | — | $0 | 3,325 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2018-02-22 | 2018-02-26 | 727 | $284.81 | $207.1K | 7,461 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2018-02-22 | 2018-02-26 | 1,635 | — | $0 | 8,188 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2018-02-20 | 2018-02-21 | 743 | $292.00 | $217.0K | 6,553 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2018-02-15 | 2018-02-20 | 1,339 | — | $0 | 5,041 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2018-02-15 | 2018-02-20 | 787 | — | $0 | 4,254 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2018-02-15 | 2018-02-20 | 596 | $299.38 | $178.4K | 8,590 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2018-02-15 | 2018-02-20 | 1,339 | — | $0 | 9,186 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2018-02-15 | 2018-02-20 | 1,294 | $298.85 | $386.7K | 7,296 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2018-02-12 | 2018-02-14 | 1,398 | — | $0 | 3,418 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2018-02-12 | 2018-02-14 | 2,012 | — | $0 | 4,816 | SEC↗ |
| BIIB BIOGEN INC. | A Award deriv | 2018-02-12 | 2018-02-14 | 8,290 | — | $0 | 8,290 | SEC↗ |
| BIIB BIOGEN INC. | A Award deriv | 2018-02-12 | 2018-02-14 | 3,315 | — | $0 | 3,315 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2018-02-12 | 2018-02-14 | 598 | $316.63 | $189.3K | 6,553 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2018-02-12 | 2018-02-14 | 718 | $316.63 | $227.3K | 7,847 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2018-02-12 | 2018-02-14 | 2,012 | — | $0 | 8,565 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2017-05-22 | 2017-06-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2017-04-03 | 2017-04-04 | 1,981 | $274.08 | $543.0K | 7,060 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2017-03-01 | 2017-03-03 | 973 | $290.07 | $282.2K | 9,041 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2017-02-28 | 2017-03-02 | 1,103 | — | $0 | 6,335 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2017-02-28 | 2017-03-02 | 628 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2017-02-28 | 2017-03-02 | 1,569 | — | $0 | 6,828 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2017-02-28 | 2017-03-02 | 398 | — | $0 | 1,062 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2017-02-28 | 2017-03-02 | 1,375 | — | $0 | 4,960 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2017-02-28 | 2017-03-02 | 662 | — | $0 | 1,460 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2017-02-28 | 2017-03-02 | 815 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2017-02-28 | 2017-03-02 | 738 | — | $0 | 628 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2017-02-28 | 2017-03-02 | 1,841 | — | $0 | 8,397 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2017-02-28 | 2017-03-02 | 1,375 | — | $0 | 9,585 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2017-02-28 | 2017-03-02 | 647 | $287.63 | $186.1K | 8,938 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2017-02-28 | 2017-03-02 | 398 | — | $0 | 9,336 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2017-02-28 | 2017-03-02 | 188 | $284.75 | $53.5K | 9,148 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2017-02-28 | 2017-03-02 | 727 | $274.76 | $199.8K | 8,421 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2017-02-28 | 2017-03-02 | 1,569 | — | $0 | 9,990 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2017-02-28 | 2017-03-02 | 384 | $274.76 | $105.5K | 10,014 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2017-02-28 | 2017-03-02 | 815 | — | $0 | 10,398 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2017-02-28 | 2017-03-02 | 296 | $274.60 | $81.3K | 9,583 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2017-02-28 | 2017-03-02 | 628 | — | $0 | 9,879 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2017-02-28 | 2017-03-02 | 739 | $274.76 | $203.0K | 9,251 | SEC↗ |
| BIIB BIOGEN INC. | A Award deriv | 2017-02-15 | 2017-02-17 | 6,380 | — | $0 | 6,380 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2016-05-20 | 2016-05-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2016-02-25 | 2016-02-26 | 183 | $261.90 | $47.9K | 7,990 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2016-02-23 | 2016-02-25 | 347 | — | $0 | 2,763 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2016-02-23 | 2016-02-25 | 689 | — | $0 | 2,074 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2016-02-23 | 2016-02-25 | 347 | — | $0 | 8,337 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2016-02-23 | 2016-02-25 | 164 | $258.99 | $42.5K | 8,173 | SEC↗ |
| BIIB BIOGEN INC. | A Award deriv | 2016-02-22 | 2016-02-24 | 7,270 | — | $0 | 7,270 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2016-02-17 | 2016-02-19 | 722 | $256.16 | $184.9K | 7,990 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2016-02-12 | 2016-02-17 | 792 | — | $0 | 797 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2016-02-12 | 2016-02-17 | 1,900 | — | $0 | 10,006 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2016-02-12 | 2016-02-17 | 573 | — | $0 | 2,095 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2016-02-12 | 2016-02-17 | 1,434 | — | $0 | 11,906 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2016-02-12 | 2016-02-17 | 759 | — | $0 | 1,336 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2016-02-12 | 2016-02-17 | 792 | — | $0 | 9,085 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2016-02-12 | 2016-02-17 | 270 | $247.22 | $66.7K | 8,293 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2016-02-12 | 2016-02-17 | 573 | — | $0 | 8,563 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2016-02-12 | 2016-02-17 | 628 | $247.22 | $155.3K | 7,112 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2016-02-12 | 2016-02-17 | 1,434 | — | $0 | 8,546 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2016-02-12 | 2016-02-17 | 373 | $247.22 | $92.2K | 8,712 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2016-02-12 | 2016-02-17 | 556 | $247.22 | $137.5K | 7,990 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2016-02-09 | 2016-02-10 | 852 | $246.54 | $210.1K | 7,740 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2016-02-08 | 2016-02-10 | 1,278 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2016-02-08 | 2016-02-10 | 426 | $250.77 | $106.8K | 8,592 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2016-02-08 | 2016-02-10 | 1,278 | — | $0 | 9,018 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2015-12-04 | 2015-12-07 | 441 | $277.00 | $122.2K | 7,740 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2015-12-03 | 2015-12-07 | 393 | $275.44 | $108.2K | 8,181 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2015-09-02 | 2015-09-04 | 40,000 | — | $0 | 40,000 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2015-03-27 | 2015-03-30 | 430 | $430.12 | $185.0K | 8,574 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2015-03-02 | 2015-03-03 | 600 | $408.98 | $245.4K | 10,378 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2015-03-02 | 2015-03-03 | 1,000 | $411.39 | $411.4K | 9,004 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2015-03-02 | 2015-03-03 | 374 | $410.57 | $153.6K | 10,004 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2015-03-02 | 2015-03-03 | 1,100 | $407.95 | $448.7K | 10,978 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2015-03-02 | 2015-03-03 | 100 | $406.40 | $40.6K | 12,078 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2015-03-01 | 2015-03-03 | 2,826 | $409.59 | $1.16M | 12,178 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award deriv | 2015-02-23 | 2015-02-25 | 3,110 | — | $0 | 3,110 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2015-02-17 | 2015-02-18 | 418 | $389.11 | $162.6K | 15,004 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2015-02-12 | 2015-02-17 | 813 | — | $0 | 3,187 | SEC↗ |
| BIIB BIOGEN IDEC INC. | J Other deriv | 2015-02-12 | 2015-02-17 | 519 | — | $0 | 2,668 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2015-02-12 | 2015-02-17 | 792 | — | $0 | 1,589 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2015-02-12 | 2015-02-17 | 813 | — | $0 | 15,805 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2015-02-12 | 2015-02-17 | 383 | $392.11 | $150.2K | 15,422 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2015-02-12 | 2015-02-17 | 792 | — | $0 | 15,366 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2015-02-12 | 2015-02-17 | 374 | $392.11 | $146.6K | 14,992 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2015-02-10 | 2015-02-11 | 643 | $398.10 | $256.0K | 14,774 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2015-02-10 | 2015-02-11 | 100 | $399.08 | $39.9K | 14,674 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2015-02-10 | 2015-02-11 | 100 | $400.22 | $40.0K | 14,574 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2015-02-10 | 2015-02-11 | 300 | $397.11 | $119.1K | 15,417 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2015-02-09 | 2015-02-10 | 1,824 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2015-02-09 | 2015-02-10 | 681 | $396.88 | $270.3K | 15,717 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2015-02-09 | 2015-02-10 | 856 | $398.05 | $340.7K | 14,574 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2015-02-09 | 2015-02-10 | 1,824 | — | $0 | 16,398 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2015-02-08 | 2015-02-10 | 1,277 | — | $0 | 1,278 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2015-02-08 | 2015-02-10 | 421 | $402.00 | $169.2K | 15,430 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2015-02-08 | 2015-02-10 | 1,277 | — | $0 | 15,851 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-12-04 | 2014-12-05 | 440 | $345.88 | $152.2K | 14,574 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2014-12-03 | 2014-12-05 | 393 | $347.34 | $136.5K | 15,014 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-03-04 | 2014-03-05 | 3,171 | $342.58 | $1.09M | 15,407 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2014-03-03 | 2014-03-04 | 2,829 | $340.68 | $963.8K | 18,578 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-02-26 | 2014-02-27 | 1,048 | $342.17 | $358.6K | 21,407 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2014-02-23 | 2014-02-25 | 1,988 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2014-02-23 | 2014-02-25 | 940 | $347.11 | $326.3K | 22,455 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2014-02-23 | 2014-02-25 | 1,988 | — | $0 | 23,395 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-02-13 | 2014-02-14 | 425 | $316.42 | $134.5K | 21,407 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award deriv | 2014-02-12 | 2014-02-14 | 13,340 | — | $0 | 13,340 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award deriv | 2014-02-12 | 2014-02-14 | 4,000 | — | $0 | 4,000 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2014-02-12 | 2014-02-14 | 792 | — | $0 | 2,381 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award | 2014-02-12 | 2014-02-14 | 7,740 | — | $0 | 21,832 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2014-02-12 | 2014-02-14 | 367 | $323.04 | $118.6K | 14,092 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2014-02-12 | 2014-02-14 | 792 | — | $0 | 14,459 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-02-11 | 2014-02-12 | 855 | $314.31 | $268.7K | 13,667 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-02-11 | 2014-02-12 | 1,230 | $314.31 | $386.6K | 14,522 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2014-02-09 | 2014-02-11 | 1,824 | — | $0 | 1,824 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2014-02-09 | 2014-02-11 | 1,824 | — | $0 | 16,346 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2014-02-09 | 2014-02-11 | 594 | $315.54 | $187.4K | 15,752 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2014-02-08 | 2014-02-11 | 1,277 | — | $0 | 2,555 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2014-02-08 | 2014-02-11 | 422 | $315.54 | $133.2K | 14,522 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2014-02-08 | 2014-02-11 | 1,277 | — | $0 | 14,944 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-12-04 | 2013-12-05 | 439 | $285.90 | $125.5K | 13,667 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2013-12-03 | 2013-12-05 | 394 | $287.76 | $113.4K | 14,106 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2013-10-22 | 2013-10-23 | 15,030 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2013-10-22 | 2013-10-23 | 15,030 | $60.56 | $910.2K | 29,530 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-10-22 | 2013-10-23 | 15,030 | $250.11 | $3.76M | 14,500 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2013-09-16 | 2013-09-18 | 9,820 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2013-09-16 | 2013-09-18 | 9,820 | $49.65 | $487.6K | 24,320 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-09-16 | 2013-09-18 | 9,820 | $240.10 | $2.36M | 14,500 | SEC↗ |